BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li L, Wang Y, Guo R, Li S, Ni J, Gao S, Gao X, Mao J, Zhu Y, Wu P, Wang H, Kong D, Zhang H, Zhu M, Fan G. Ginsenoside Rg3-loaded, reactive oxygen species-responsive polymeric nanoparticles for alleviating myocardial ischemia-reperfusion injury. J Control Release 2020;317:259-72. [PMID: 31783047 DOI: 10.1016/j.jconrel.2019.11.032] [Cited by in Crossref: 50] [Cited by in F6Publishing: 40] [Article Influence: 12.5] [Reference Citation Analysis]
Number Citing Articles
1 Balusamy SR, Perumalsamy H, Huq MA, Yoon TH, Mijakovic I, Thangavelu L, Yang DC, Rahimi S. A comprehensive and systemic review of ginseng-based nanomaterials: Synthesis, targeted delivery, and biomedical applications. Med Res Rev 2023. [PMID: 36939049 DOI: 10.1002/med.21953] [Reference Citation Analysis]
2 Jung WH, Song J, You G, Lee JH, Lee SW, Ahn JH, Mok H. Protection of Skin Fibroblasts from Infrared-A-Induced Photo-Damage Using Ginsenoside Rg3(S)-Incorporated Soybean Lecithin Liposomes. J Microbiol Biotechnol 2023;33:135-41. [PMID: 36575857 DOI: 10.4014/jmb.2210.10048] [Reference Citation Analysis]
3 Kim J, Zhu Y, Wang R, Wang J. Amelioration of colitis progression by ginseng-derived exosome-like nanoparticles through suppression of inflammatory cytokines. Journal of Ginseng Research 2023. [DOI: 10.1016/j.jgr.2023.01.004] [Reference Citation Analysis]
4 Zhang X, Zhao X, Hua Z, Xing S, Li J, Fei S, Tan M. ROS-triggered self-disintegrating and pH-responsive astaxanthin nanoparticles for regulating the intestinal barrier and colitis. Biomaterials 2023;292:121937. [PMID: 36495803 DOI: 10.1016/j.biomaterials.2022.121937] [Reference Citation Analysis]
5 Wang J, Liu Y, Liu Y, Huang H, Roy S, Song Z, Guo B. Recent advances in nanomedicines for imaging and therapy of myocardial ischemia-reperfusion injury. J Control Release 2023;353:563-90. [PMID: 36496052 DOI: 10.1016/j.jconrel.2022.11.057] [Reference Citation Analysis]
6 Shi A, Zeng Y, Xin D, Zhou Y, Zhao L, Peng J. Real-Time Visualization of the Antioxidative Potency of Drugs for the Prevention of Myocardium Ischemia-Reperfusion Injury by a NIR Fluorescent Nanoprobe. ACS Sens 2022;7:3867-75. [PMID: 36441913 DOI: 10.1021/acssensors.2c01857] [Reference Citation Analysis]
7 Zhao L, Ling L, Lu J, Jiang F, Sun J, Zhang Z, Huang Y, Liu X, Zhu Y, Fu X, Peng S, Yuan W, Zhao R, Zhang Z. Reactive oxygen species‐responsive mitochondria‐targeted liposomal quercetin attenuates retinal ischemia–reperfusion injury via regulating SIRT1 / FOXO3A and p38 MAPK signaling pathways. Bioengineering & Transla Med 2022. [DOI: 10.1002/btm2.10460] [Reference Citation Analysis]
8 Ismail EA, Devnarain N, Govender T, Omolo CA. Stimuli-responsive and biomimetic delivery systems for sepsis and related complications. J Control Release 2022;352:1048-70. [PMID: 36372385 DOI: 10.1016/j.jconrel.2022.11.013] [Reference Citation Analysis]
9 Yang H, Zhou P, Li Q, Zhou X, Li J, Wang J, Wang J, Zhao Y, Yang B, Zhang B, Dai C, Zou Z, Yang Y, Chen Z. TJ-M2010-5 Attenuates Severe Myocardial Ischemia/Reperfusion Injury in Heart Transplantation by Inhibiting MyD88 Homodimerization In Vivo. J Cardiovasc Transl Res 2022;15:1366-76. [PMID: 35411418 DOI: 10.1007/s12265-022-10246-9] [Reference Citation Analysis]
10 Shofolawe-Bakare OT, de Mel JU, Mishra SK, Hossain M, Hamadani CM, Pride MC, Dasanayake GS, Monroe W, Roth EW, Tanner EEL, Doerksen RJ, Smith AE, Werfel TA. ROS-Responsive Glycopolymeric Nanoparticles for Enhanced Drug Delivery to Macrophages. Macromol Biosci 2022;22:e2200281. [PMID: 36125638 DOI: 10.1002/mabi.202200281] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Fan ZX, Yang CJ, Li YH, Yang J, Huang CX. Ginsenoside Rh2 attenuates myocardial ischaemia‑reperfusion injury by regulating the Nrf2/HO‑1/NLRP3 signalling pathway. Exp Ther Med 2023;25:35. [PMID: 36569435 DOI: 10.3892/etm.2022.11734] [Reference Citation Analysis]
12 Zhang HE, Chu MY, Jiang T, Song XH, Hou JF, Cheng LY, Feng Y, Chen CB, Wang EP. By-Product of the Red Ginseng Manufacturing Process as Potential Material for Use as Cosmetics: Chemical Profiling and In Vitro Antioxidant and Whitening Activities. Molecules 2022;27. [PMID: 36500294 DOI: 10.3390/molecules27238202] [Reference Citation Analysis]
13 Huang C, Zhou S, Chen C, Wang X, Ding R, Xu Y, Cheng Z, Ye Z, Sun L, Wang ZJ, Hu D, Jia X, Zhang G, Gao S. Biodegradable Redox-Responsive AIEgen-Based-Covalent Organic Framework Nanocarriers for Long-Term Treatment of Myocardial Ischemia/Reperfusion Injury. Small 2022;18:e2205062. [PMID: 36251781 DOI: 10.1002/smll.202205062] [Reference Citation Analysis]
14 Han Z, Gao X, Wang Y, Cheng S, Zhong X, Xu Y, Zhou X, Zhang Z, Liu Z, Cheng L. Ultrasmall iron-quercetin metal natural product nanocomplex with antioxidant and macrophage regulation in rheumatoid arthritis. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.11.020] [Reference Citation Analysis]
15 Pan Z, Guo J, Tang K, Chen Y, Gong X, Chen Y, Zhong Y, Xiao X, Duan S, Cui T, Wu X, Zhong Y, Yang X, Shen C, Gao Y. Ginsenoside Rc Modulates SIRT6-NRF2 Interaction to Alleviate Alcoholic Liver Disease. J Agric Food Chem 2022. [DOI: 10.1021/acs.jafc.2c06146] [Reference Citation Analysis]
16 Wang J, Zeng L, Zhang Y, Qi W, Wang Z, Tian L, Zhao D, Wu Q, Li X, Wang T. Pharmacological properties, molecular mechanisms and therapeutic potential of ginsenoside Rg3 as an antioxidant and anti-inflammatory agent. Front Pharmacol 2022;13:975784. [DOI: 10.3389/fphar.2022.975784] [Reference Citation Analysis]
17 Hafiz I, Li Z, Wang Z, He H, Tang X, Wang M. Improving the antitumor efficiency against hepatocellular carcinoma by harmine-loaded liposomes with mitochondria targeting and legumain response. Journal of Drug Delivery Science and Technology 2022;75:103623. [DOI: 10.1016/j.jddst.2022.103623] [Reference Citation Analysis]
18 Cicha I, Priefer R, Severino P, Souto EB, Jain S. Biosensor-Integrated Drug Delivery Systems as New Materials for Biomedical Applications. Biomolecules 2022;12:1198. [DOI: 10.3390/biom12091198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 He S, Wu L, Sun H, Wu D, Wang C, Ren X, Shao Q, York P, Tong J, Zhu J, Li Z, Zhang J. Antioxidant Biodegradable Covalent Cyclodextrin Frameworks as Particulate Carriers for Inhalation Therapy against Acute Lung Injury. ACS Appl Mater Interfaces 2022. [PMID: 35948492 DOI: 10.1021/acsami.2c05220] [Reference Citation Analysis]
20 Ke Y, Huang L, Song Y, Liu Z, Liang L, Wang L, Wang T. Preparation and pharmacological effects of minor ginsenoside nanoparticles: a review. Front Pharmacol 2022;13:974274. [DOI: 10.3389/fphar.2022.974274] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Zhong Y, Zeng X, Zeng Y, Yang L, Peng J, Zhao L, Chang Y. Nanomaterials-based imaging diagnosis and therapy of cardiovascular diseases. Nano Today 2022;45:101554. [DOI: 10.1016/j.nantod.2022.101554] [Reference Citation Analysis]
22 Liao X, Song X, Li J, Li L, Fan X, Qin Q, Zhong C, Yang P, Zhan J, Cai Y. An injectable co-assembled hydrogel blocks reactive oxygen species and inflammation cycle resisting myocardial ischemia-reperfusion injury. Acta Biomater 2022:S1742-7061(22)00378-6. [PMID: 35777549 DOI: 10.1016/j.actbio.2022.06.039] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Genç H, Efthimiadou E, Cicha I. On-Demand Drug Delivery: Recent Advances in Cardiovascular Applications. Front Drug Deliv 2022;2. [DOI: 10.3389/fddev.2022.913225] [Reference Citation Analysis]
24 Wei Q, Ren Y, Zheng X, Yang S, Lu T, Ji H, Hua H, Shan K. Ginsenoside Rg3 and sorafenib combination therapy relieves the hepatocellular carcinomaprogression through regulating the HK2-mediated glycolysis and PI3K/Akt signaling pathway. Bioengineered 2022;13:13919-28. [PMID: 35719058 DOI: 10.1080/21655979.2022.2074616] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Liu M, Liu S, Zhu X, Sun Y, Su L, Yu H, Liu D, Li Y, Du Y, Liu R, Sun K. Tanshinone IIA-loaded Micelles functionalized with Rosmarinic acid: A novel Synergistic Anti-inflammatory strategy for treatment of Atherosclerosis. Journal of Pharmaceutical Sciences 2022. [DOI: 10.1016/j.xphs.2022.05.007] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Bai C, Ma Q, Li Q, Yu L, Zhen D, Liu M, Wei C. Combination of 1,8-Cineole and Beta-Caryophyllene Synergistically Reverses Cardiac hypertrophy in Isoprenaline-Induced mice and H9c2 cells. Bioorganic Chemistry 2022. [DOI: 10.1016/j.bioorg.2022.105823] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Tapeinos C, Gao H, Bauleth‐ramos T, Santos HA. Progress in Stimuli‐Responsive Biomaterials for Treating Cardiovascular and Cerebrovascular Diseases. Small. [DOI: 10.1002/smll.202200291] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Chen Z, Wu J, Li S, Liu C, Ren Y. Inhibition of Myocardial Cell Apoptosis Is Important Mechanism for Ginsenoside in the Limitation of Myocardial Ischemia/Reperfusion Injury. Front Pharmacol 2022;13:806216. [PMID: 35300297 DOI: 10.3389/fphar.2022.806216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Chopra H, Bibi S, Mishra AK, Tirth V, Yerramsetty SV, Murali SV, Ahmad SU, Mohanta YK, Attia MS, Algahtani A, Islam F, Hayee A, Islam S, Baig AA, Emran TB, Senthilkumar N. Nanomaterials: A Promising Therapeutic Approach for Cardiovascular Diseases. Journal of Nanomaterials 2022;2022:1-25. [DOI: 10.1155/2022/4155729] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
30 Xie J, Yao Y, Wang S, Fan L, Ding J, Gao Y, Li S, Shen L, Zhu Y, Gao C. Alleviating Oxidative Injury of Myocardial Infarction by a Fibrous Polyurethane Patch with Condensed ROS-Scavenging Backbone Units. Adv Healthc Mater 2022;11:e2101855. [PMID: 34811967 DOI: 10.1002/adhm.202101855] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
31 Cardoso VMDO, Ferreira LMB, Comparetti EJ, Sampaio I, Ferreira NN, Miranda RR, Zucolotto V. Stimuli-responsive polymeric nanoparticles as controlled drug delivery systems. Stimuli-Responsive Nanocarriers 2022. [DOI: 10.1016/b978-0-12-824456-2.00011-4] [Reference Citation Analysis]
32 Li Q, Xu M, Li Z, Li T, Wang Y, Chen Q, Wang Y, Feng J, Yin X, Lu C. Maslinic Acid Attenuates Ischemia/Reperfusion Injury-Induced Myocardial Inflammation and Apoptosis by Regulating HMGB1-TLR4 Axis. Front Cardiovasc Med 2021;8:768947. [PMID: 34859077 DOI: 10.3389/fcvm.2021.768947] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Li X, Zhang Y, Ren X, Wang Y, Chen D, Li Q, Huo M, Shi J. Ischemic Microenvironment-Responsive Therapeutics for Cardiovascular Diseases. Adv Mater 2021;33:e2105348. [PMID: 34623714 DOI: 10.1002/adma.202105348] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
34 Liu Y, Zhang X, Wu T, Liu B, Yang J, Liu W. Chinese herb-crosslinked hydrogel bearing rBMSCs-laden polyzwitterion microgels: Self-adaptive manipulation of micromilieu and stemness maintenance for restoring infarcted myocardium. Nano Today 2021;41:101306. [DOI: 10.1016/j.nantod.2021.101306] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
35 Han HS, Koo SY, Choi KY. Emerging nanoformulation strategies for phytocompounds and applications from drug delivery to phototherapy to imaging. Bioactive Materials 2021. [DOI: 10.1016/j.bioactmat.2021.11.027] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
36 Qin H, Li S, Liu Z. Protective Effect of Shexiang Baoxin Pill on Myocardial Ischemia/Reperfusion Injury in Patients With STEMI. Front Pharmacol 2021;12:721011. [PMID: 34603032 DOI: 10.3389/fphar.2021.721011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Zhao T, Wu W, Sui L, Huang Q, Nan Y, Liu J, Ai K. Reactive oxygen species-based nanomaterials for the treatment of myocardial ischemia reperfusion injuries. Bioact Mater 2022;7:47-72. [PMID: 34466716 DOI: 10.1016/j.bioactmat.2021.06.006] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 30.0] [Reference Citation Analysis]
38 Ma Y, Li P, Zhao L, Liu J, Yu J, Huang Y, Zhu Y, Li Z, Zhao R, Hua S, Zhu Y, Zhang Z. Size-Dependent Cytotoxicity and Reactive Oxygen Species of Cerium Oxide Nanoparticles in Human Retinal Pigment Epithelia Cells. Int J Nanomedicine 2021;16:5333-41. [PMID: 34408413 DOI: 10.2147/IJN.S305676] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
39 Ma B, Xu H, Wang Y, Yang L, Zhuang W, Li G, Wang Y. Biomimetic-Coated Nanoplatform with Lipid-Specific Imaging and ROS Responsiveness for Atherosclerosis-Targeted Theranostics. ACS Appl Mater Interfaces 2021;13:35410-21. [PMID: 34286950 DOI: 10.1021/acsami.1c08552] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
40 Rumanti AP, Maruf A, Liu H, Ge S, Lei D, Wang G. Engineered bioresponsive nanotherapeutics: recent advances in the treatment of atherosclerosis and ischemic-related disease. J Mater Chem B 2021;9:4804-25. [PMID: 34085084 DOI: 10.1039/d1tb00330e] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
41 Ren B, Feng J, Yang N, Guo Y, Chen C, Qin Q. Ginsenoside Rg3 attenuates angiotensin II-induced myocardial hypertrophy through repressing NLRP3 inflammasome and oxidative stress via modulating SIRT1/NF-κB pathway. Int Immunopharmacol 2021;98:107841. [PMID: 34153662 DOI: 10.1016/j.intimp.2021.107841] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
42 Ni J, Liu Z, Jiang M, Li L, Deng J, Wang X, Su J, Zhu Y, He F, Mao J, Gao X, Fan G. Ginsenoside Rg3 ameliorates myocardial glucose metabolism and insulin resistance via activating the AMPK signaling pathway. Journal of Ginseng Research 2021. [DOI: 10.1016/j.jgr.2021.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Guan Y, Yao W, Yi K, Zheng C, Lv S, Tao Y, Hei Z, Li M. Nanotheranostics for the Management of Hepatic Ischemia-Reperfusion Injury. Small 2021;17:e2007727. [PMID: 33852769 DOI: 10.1002/smll.202007727] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
44 Qiao L, Han M, Gao S, Shao X, Wang X, Sun L, Fu X, Wei Q. Research progress on nanotechnology for delivery of active ingredients from traditional Chinese medicines. J Mater Chem B 2020;8:6333-51. [PMID: 32633311 DOI: 10.1039/d0tb01260b] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 6.5] [Reference Citation Analysis]
45 Fu Z, Xu YS, Cai CQ. Ginsenoside Rg3 inhibits pulmonary fibrosis by preventing HIF-1α nuclear localisation. BMC Pulm Med 2021;21:70. [PMID: 33639908 DOI: 10.1186/s12890-021-01426-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
46 Yin M, Li C, Jiang J, Le J, Luo B, Yang F, Fang Y, Yang M, Deng Z, Ni W, Shao J. Cell adhesion molecule-mediated therapeutic strategies in atherosclerosis: From a biological basis and molecular mechanism to drug delivery nanosystems. Biochem Pharmacol 2021;186:114471. [PMID: 33587918 DOI: 10.1016/j.bcp.2021.114471] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
47 Sarhene M, Ni JY, Duncan ES, Liu Z, Li S, Zhang J, Guo R, Gao S, Gao X, Fan G. Ginsenosides for cardiovascular diseases; update on pre-clinical and clinical evidence, pharmacological effects and the mechanisms of action. Pharmacol Res 2021;166:105481. [PMID: 33549726 DOI: 10.1016/j.phrs.2021.105481] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
48 Kang Z, Zhonga Y, Wu T, Huang J, Zhao H, Liu D. Ginsenoside from ginseng: a promising treatment for inflammatory bowel disease. Pharmacol Rep 2021;73:700-11. [PMID: 33462754 DOI: 10.1007/s43440-020-00213-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
49 Hernández-fontes P, Lozano O, García-rivas G. Nanomaterials aimed toward the cardiac mitochondria: from therapeutics to nanosafety. Mitochondrial Dysfunction and Nanotherapeutics 2021. [DOI: 10.1016/b978-0-323-85666-9.00002-4] [Reference Citation Analysis]
50 Gao S, Wang L, Zhang Y, Li L, Zhang Y, Gao X, Mao J, Wang L, Wang L, Wang H, Zhu M, Fan G. Tanshinone IIA-loaded aligned microfibers facilitate stem cell recruitment and capillary formation by inducing M2 macrophage polarization. Applied Materials Today 2020;21:100841. [DOI: 10.1016/j.apmt.2020.100841] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Zang X, Zhou J, Zhang X, Han Y, Chen X. Ischemia Reperfusion Injury: Opportunities for Nanoparticles. ACS Biomater Sci Eng 2020;6:6528-39. [PMID: 33320610 DOI: 10.1021/acsbiomaterials.0c01197] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
52 Yin Dou, Chenwen Li, Lanlan Li, Jiawei Guo, Jianxiang Zhang. Bioresponsive drug delivery systems for the treatment of inflammatory diseases. J Control Release 2020;327. [PMID: 32911014 DOI: 10.1016/j.jconrel.2020.09.008] [Cited by in Crossref: 67] [Cited by in F6Publishing: 47] [Article Influence: 22.3] [Reference Citation Analysis]
53 Zhou W, Lin D, Zhong Z, Ye Q. Roles of TRAFs in Ischemia-Reperfusion Injury. Front Cell Dev Biol 2020;8:586487. [PMID: 33224951 DOI: 10.3389/fcell.2020.586487] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
54 Liu J, Li Y, Chen S, Lin Y, Lai H, Chen B, Chen T. Biomedical Application of Reactive Oxygen Species-Responsive Nanocarriers in Cancer, Inflammation, and Neurodegenerative Diseases. Front Chem 2020;8:838. [PMID: 33062637 DOI: 10.3389/fchem.2020.00838] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
55 Luan P, Ding X, Xu J, Jiang L, Xu Y, Zhu Y, Li R, Zhang J. Salvianolate reduces neuronal apoptosis by suppressing OGD-induced microglial activation. Life Sci 2020;260:118393. [PMID: 32898527 DOI: 10.1016/j.lfs.2020.118393] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Chen W, Li D. Reactive Oxygen Species (ROS)-Responsive Nanomedicine for Solving Ischemia-Reperfusion Injury. Front Chem 2020;8:732. [PMID: 32974285 DOI: 10.3389/fchem.2020.00732] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 10.0] [Reference Citation Analysis]
57 Cristallini C, Vitale E, Giachino C, Rastaldo R. Nanoengineering in Cardiac Regeneration: Looking Back and Going Forward. Nanomaterials (Basel) 2020;10:E1587. [PMID: 32806691 DOI: 10.3390/nano10081587] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
58 Xue Q, He N, Wang Z, Fu X, Aung LHH, Liu Y, Li M, Cho JY, Yang Y, Yu T. Functional roles and mechanisms of ginsenosides from Panax ginseng in atherosclerosis. J Ginseng Res 2021;45:22-31. [PMID: 33437153 DOI: 10.1016/j.jgr.2020.07.002] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 14.3] [Reference Citation Analysis]
59 K SK, Asokan A. Hypo-Fractionated Radiotherapy for Laryngeal Cancer; is Linac Based Treatment Better? jemds 2019;8:3946-3952. [DOI: 10.14260/jemds/2019/854] [Reference Citation Analysis]